Assessment of a new RNA stabilizing reagent (Tempus Blood RNA) for minimal residual disease in onco-hematology using the EAC protocol.
第一作者:
Nicolas,Prezeau
第一单位:
Department of Biochemistry & Molecular Biology, Hôpital Universitaire Nord, ERT-MEIDIA, IFR Jean Roche, Université de la Méditerranée, Marseille, France.
作者:
医学主题词
细胞系, 肿瘤(Cell Line, Tumor);欧洲(Europe);血液肿瘤(Hematologic Neoplasms);人类(Humans);指示剂和试剂(Indicators and Reagents);K562细胞(K562 Cells);肿瘤, 残余(Neoplasm, Residual);癌基因蛋白质类, 融合(Oncogene Proteins, Fusion);RNA(RNA);RNA稳定性(RNA Stability);试剂盒, 诊断(Reagent Kits, Diagnostic);结果可重复性(Reproducibility of Results);逆转录聚合酶链反应(Reverse Transcriptase Polymerase Chain Reaction);敏感性与特异性(Sensitivity and Specificity);转录, 遗传(Transcription, Genetic)
DOI
10.1016/j.leukres.2005.08.027
PMID
16209886
发布时间
2019-12-10
- 浏览16
Leukemia research
569-74页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



